LANOXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lanoxin, and when can generic versions of Lanoxin launch?
Lanoxin is a drug marketed by Covis and Concordia and is included in two NDAs.
The generic ingredient in LANOXIN is digoxin. There are ten drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the digoxin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lanoxin
A generic version of LANOXIN was approved as digoxin by RISING on December 23rd, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LANOXIN?
- What are the global sales for LANOXIN?
- What is Average Wholesale Price for LANOXIN?
Summary for LANOXIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 87 |
| Clinical Trials: | 18 |
| Drug Prices: | Drug price information for LANOXIN |
| What excipients (inactive ingredients) are in LANOXIN? | LANOXIN excipients list |
| DailyMed Link: | LANOXIN at DailyMed |
Recent Clinical Trials for LANOXIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Turning Point Therapeutics, Inc. | Phase 1 |
| Yale University | Phase 2 |
| Jean Grem, MD | Phase 2 |
Pharmacology for LANOXIN
| Drug Class | Cardiac Glycoside |
US Patents and Regulatory Information for LANOXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Covis | LANOXIN | digoxin | INJECTABLE;INJECTION | 009330-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Concordia | LANOXIN | digoxin | TABLET;ORAL | 020405-006 | Sep 30, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Concordia | LANOXIN | digoxin | TABLET;ORAL | 020405-003 | Sep 30, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
